Galmed Pharmaceuticals (GLMD) Other Accumulated Expenses (2019 - 2025)

Galmed Pharmaceuticals' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $500000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses changed 0.0% year-over-year to $500000.0; the TTM figure through Dec 2025 stood at $500000.0 (changed 0.0% YoY), while the FY2025 annual figure was $500000.0, changed 0.0% from the prior year.
• Other Accumulated Expenses was $500000.0 for Q4 2025 at Galmed Pharmaceuticals, down from $798000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.4 million in Q2 2021 to a low of $200000.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $746500.0 across 5 years, with a median of $608500.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses tumbled 80.16% in 2022, then surged 200.0% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $1.0 million in 2021, then sank by 80.16% to $200000.0 in 2022, then soared by 200.0% to $600000.0 in 2023, then retreated by 16.67% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $500000.0 (Q4 2025), $798000.0 (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.